Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Visiting Researcher Grants 2025

Danish Diabetes and Endocrine Academy (DDEA)

The Danish Diabetes and Endocrine Academy (DDEA) invites applications for six Visiting Researcher Grants.

Applications can be in any research field within diabetes, metabolism or endocrinology.

These grants include salary costs, travel and accommodation expenses for international senior researchers who visit research Institutions in Denmark during 2026 and 2027 (up to a maximum of DKK 400,000 in total). These visits aim to strengthen international research exchange, foster new ideas, and build lasting partnerships across borders.

The visiting researcher grants may also be further enhanced by separate application for a DDEA Strategic Partnership PhD scholarship or DDEA Strategic Partnership Postdoctoral Fellowship, if relevant.

Deadline for application is 20 August 2025 at 23:59 CET with expected date of reply 26 November 2025.

evaluation criteria

The DDEA Secretariat will process all incoming applications. Applications not fulfilling the eligibility criteria and/or technical requirements will not be considered.

All eligible applications will be submitted to the DDEA Grant Review Committee for a scientific evaluation. Evaluation of the applications will consider four evaluation criteria: 1) the applicant; 2) the project; 3) the research environment; and 4) the DDEA four funding focus areas: internationalisation, interdisciplinarity, collaboration across sectors, and patient and/or public involvement.

For further information about the evaluation procedure, selection process and evaluation criteria (including the DDEA funding focus areas)

Specialties

Diabetes

Endocrinology and Diabetes

Eligibility Requirements

In order to apply for a Visiting Researcher Grant, the following requirements must be fulfilled:

Application can be submitted by senior academics (senior lecturer/associate professor or above).
At the time of allocation of the grant, you must be employed at a university outside Denmark.
You must be able to document your intended collaboration with one or more researchers at a Danish research institution (a letter of support from the collaborating host principal investigator should be included).
You must have an academic degree at PhD level or higher.
You must have an excellent academic record.
You must be able to document teaching experience.
You must be willing to teach/give lectures or participate in organising education or networking activities offered by DDEA and/or review applications for DDEA.

Sponsor Details

Sponsor Institute/Organizations: Danish Diabetes and Endocrine Academy (DDEA)

Sponsor Type: Corporate/Non-Profit

Address: Odense University Hospital Kløvervænget 6 Entrance 93, 8th floor DK-5000 Odense C

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity